Literature DB >> 29970675

Triptolide: A new star for treating human malignancies.

Ping Yan1, Xiaotian Sun2.   

Abstract

In recent years, cancer has become the most common human disease worldwide, and great attentions have been paid to clarifying the carcinogenesis and identifying new effective antitumor therapy. Although great progress has been made in this research field, human malignant diseases could still not be radically cured. Thunder god vine is a herbal medicine, which has proved to exert efficient antitumor activity in various human cancers such as lung cancer, pancreatic cancer, and colon cancer. In vivo and in vitro experiments showed that thunder god vine extract triptolide could inhibit tumor cell proliferation, cell migration, and cell invasion. Here, we overviewed the functional role of triptolide in human malignancies and its promising therapeutic potential in treating such deadly diseases.

Entities:  

Keywords:  Cancer; Chinese herb; therapy; thunder god vine; triptolide

Mesh:

Substances:

Year:  2018        PMID: 29970675     DOI: 10.4103/0973-1482.235340

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  9 in total

Review 1.  Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms.

Authors:  Essa M Bajalia; Farah B Azzouz; Danielle A Chism; Derrek M Giansiracusa; Carina G Wong; Kristina N Plaskett; Anupam Bishayee
Journal:  Cancers (Basel)       Date:  2022-07-04       Impact factor: 6.575

2.  Jolkinolide B induces cell cycle arrest and apoptosis in MKN45 gastric cancer cells and inhibits xenograft tumor growth in vivo.

Authors:  Hao Zhang; Jiayi Qian; Ming Jin; Li Fan; SongJie Fan; Hong Pan; Yang Li; Ningning Wang; Baiyu Jian
Journal:  Biosci Rep       Date:  2022-06-30       Impact factor: 3.976

3.  Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones.

Authors:  Yulin Ren; A Douglas Kinghorn
Journal:  J Med Chem       Date:  2020-12-08       Impact factor: 7.446

4.  Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis.

Authors:  Bufu Tang; Jinyu Zhu; Baohui Zhang; Fazong Wu; Yajie Wang; Qiaoyou Weng; Shiji Fang; Liyun Zheng; Yang Yang; Rongfang Qiu; Minjiang Chen; Min Xu; Zhongwei Zhao; Jiansong Ji
Journal:  Front Immunol       Date:  2020-11-09       Impact factor: 7.561

Review 5.  The Roles of Plant-Derived Triptolide on Non-Small Cell Lung Cancer.

Authors:  Jie Wei; Yuanliang Yan; Xi Chen; Long Qian; Shuangshuang Zeng; Zhi Li; Shuang Dai; Zhicheng Gong; Zhijie Xu
Journal:  Oncol Res       Date:  2019-04-08       Impact factor: 5.574

Review 6.  MicroRNAs as crucial mediators in the pharmacological activities of triptolide (Review).

Authors:  Kun Zhou; Yinxia Chang; Bo Han; Rui Li; Yanming Wei
Journal:  Exp Ther Med       Date:  2021-03-17       Impact factor: 2.447

7.  Triptolide attenuates inhibition of ankylosing spondylitis-derived mesenchymal stem cells on the osteoclastogenesis through modulating exosomal transfer of circ-0110634.

Authors:  Wei Ji; Yueyang Lu; Zhuoyi Ma; Ke Gan; Yan Liu; Yue Cheng; Junliang Xu; Shijia Liu; Yunke Guo; Shanhang Han; Zengyan Zhao; Hanmei Xu; Weiyan Qi
Journal:  J Orthop Translat       Date:  2022-09-16       Impact factor: 4.889

Review 8.  Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives.

Authors:  Jie Gao; Yifeng Zhang; Xihong Liu; Xiayi Wu; Luqi Huang; Wei Gao
Journal:  Theranostics       Date:  2021-05-24       Impact factor: 11.556

9.  Triptolide interrupts rRNA synthesis and induces the RPL23‑MDM2‑p53 pathway to repress lung cancer cells.

Authors:  Juan Wang; Zhi-Qian Zhang; Fang-Qiong Li; Jia-Ning Chen; Xiaoting Gong; Bei-Bei Cao; Wei Wang
Journal:  Oncol Rep       Date:  2020-03-30       Impact factor: 3.906

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.